DataM Intelligence | competitive Intelligence NF1 drug development accelerates with novel treatments aiming to surpass current MEK inhibito ...

Surgery is the go-to treatment for cutaneous squamous cell carcinoma (CSCC) — a type of cancer that develops in the squamous cells of the skin. But there are other ways to treat the cancer if a ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Objective Neurofibromatosis type 1 (NF1) causes neural and cutaneous disorders and reduced exercise capacity. Exercise/heat exposure increasing internal temperature must be compensated by eccrine ...

In this regard, the correct definition of cutaneous manifestations associated with diabetes mellitus can help define the etiology of hyperglycemia as well as the need to optimize glycemic control. In ...

A new study co-led by Mass General Brigham researchers points to a promising new type of auditory brainstem implant (ABI) that could benefit people who are deaf due to Neurofibromatosis type 2 ...

and assessing preliminary efficacy on target plexiform neurofibroma volume and cutaneous neurofibromas. Part A of the trial will enrol up to 24 subjects who will be given one of four planned PAS ...

Exploratory objectives include assessing the effects of PAS-004 on cutaneous neurofibromas. The first active clinical trial site is the Royal North Shore Hospital in Sydney, Australia, which is ...

Secondary objectives include identifying the recommended Part B dose or maximum tolerated dose, characterising the PK and PD profiles, and assessing preliminary efficacy on target plexiform ...

Exploratory objectives include assessing the effects of PAS-004 on cutaneous neurofibromas. Pasithea has selected Novotech (Australia) Pty Limited as its clinical research organization (CRO ...